# OCULAR THERAPEUTIX, INC (OCUL) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from OCULAR THERAPEUTIX, INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/OCUL/mda/fy2025/): filed 2026-02-05; accession 0001104659-26-010664 (https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/ocul-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/OCUL/mda/fy2024/): filed 2025-03-03; accession 0001558370-25-002000 (https://www.sec.gov/Archives/edgar/data/1393434/000155837025002000/ocul-20241231x10k.htm)
- [FY 2023 MD&A](/company/OCUL/mda/fy2023/): filed 2024-03-11; accession 0001558370-24-002902 (https://www.sec.gov/Archives/edgar/data/1393434/000155837024002902/ocul-20231231x10k.htm)
- [FY 2022 MD&A](/company/OCUL/mda/fy2022/): filed 2023-03-06; accession 0001558370-23-002908 (https://www.sec.gov/Archives/edgar/data/1393434/000155837023002908/ocul-20221231x10k.htm)
- [FY 2021 MD&A](/company/OCUL/mda/fy2021/): filed 2022-02-28; accession 0001558370-22-002363 (https://www.sec.gov/Archives/edgar/data/1393434/000155837022002363/ocul-20211231x10k.htm)

Back to /company/OCUL/